Loading data
LRNNYSE
| Unit: USD | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|---|
| Revenue | 2.52 bn USD | 2.41 bn USD | 2.04 bn USD | 1.84 bn USD | 1.69 bn USD |
| Cost of revenue | 1.57 bn USD | 1.46 bn USD | 1.28 bn USD | 1.19 bn USD | 1.09 bn USD |
| Gross profit | 950.6 m USD | 943.92 m USD | 763.6 m USD | 647.07 m USD | 596.48 m USD |
| Research and development expense | 22 m USD | 16.6 m USD | 16.7 m USD | 15.5 m USD | 7.5 m USD |
| Selling, general and administrative expense | 499.83 m USD | 524.35 m USD | 514 m USD | 481.57 m USD | 439.85 m USD |
| Operating profit | 450.77 m USD | 360.09 m USD | 249.6 m USD | 165.5 m USD | 156.63 m USD |
| Profit before tax | 440.96 m USD | 380.95 m USD | 268.67 m USD | 172.21 m USD | 147.22 m USD |
| Income tax expense | 102.77 m USD | 93.01 m USD | 64.48 m USD | 45.35 m USD | 40.09 m USD |
| Net income (reported basis) | 338.19 m USD | 287.94 m USD | 204.18 m USD | 126.87 m USD | 107.13 m USD |
| Basic earnings per share | 7.92 USD/share | 6.69 USD/share | 4.79 USD/share | 3 USD/share | 2.58 USD/share |
| Diluted earnings per share | 7.14 USD/share | 5.95 USD/share | 4.69 USD/share | 2.97 USD/share | 2.52 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.